Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 01:03 am EDT
Share
Seegene, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 128,440.42 million compared to KRW 303,733.64 million a year ago. Net income was KRW 25,150.12 million compared to KRW 115,497.09 million a year ago. Basic earnings per share from continuing operations was KRW 494 compared to KRW 2,225 a year ago. Basic earnings per share was KRW 494 compared to KRW 2,225 a year ago.
For the six months, sales was KRW 579,892.18 million compared to KRW 655,483.74 million a year ago. Net income was KRW 190,622.13 million compared to KRW 280,124.28 million a year ago. Basic earnings per share from continuing operations was KRW 3,720 compared to KRW 5,393 a year ago. Basic earnings per share was KRW 3,720 compared to KRW 5,393 a year ago.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
SEEGENE, INC. 
